Slides | Structural determinants of lipoprotein(a) pathogenicity
Slides (presentation) - May 24, 2019 - Maastricht, The Netherlands - Marlys Koschinsky, PhD, FAHA, FNLA - London, ONT, Canada
Slides as educational service to PACE members and meeting participants
Slides | Phase II data, followed by NHLBI recommendation
Slides (presentation) - May 24, 2019 - Maastricht, The Netherlands - Sam Tsimikas, MD - San Diego, CA, USA - EAS endorsed satellite meeting held prior to the 87th EAS congress
Slides as educational service to PACE members and meeting participants
Slides | Prevalence and relevance of Lp(a) in familial hypercholesterolemia
Slides (presentation) - May 24, 2019 - Maastricht, The Netherlands - Børge Nordestgaard, MD, DMSc - Copenhagen, Denmark - EAS endorsed satellite meeting held prior to the 87th EAS congress
Slides as educational service to PACE members and meeting participants
Slides | Are we ready for prime-time assay standardisation?
Slides (presentation) - May 24, 2019 - Maastricht, The Netherlands - Santica Marcovina, PhD, ScD - Seattle, WA, USA - EAS endorsed satellite meeting held prior to the 87th EAS congress
Slides as educational service to PACE members and meeting participants
Slides | Lp(a) (genetics/plasma) and CV morbidity and mortality
Slides (presentation) - May 24, 2019 - Maastricht, The Netherlands - Pia Kamstrup, MD, PhD - Copenhagen, Denmark - EAS endorsed satellite meeting held prior to the 87th EAS congress
Slides as educational service to PACE members and meeting participants
